Prevalence of human papillomavirus in tonsil brushings and gargles in cancer-free patients: The SPLIT study

Oral Oncology

Volumn 66, Issue , 2017, Pages 52-57

  Combes, Jean Damien ^a   Dalstein, Véronique ^b,c,d   Gheit, Tarik ^a   Clifford, Gary M ^a   Tommasino, Massimo ^a   Clavel, Christine ^b,c,d   Lacau St Guily, Jean ^e   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

HPV; Oral HPV; Oropharyngeal neoplasms; Tonsil; Tonsillectomy

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CHILD; DNA DETERMINATION; EX VIVO STUDY; FEMALE; GARGLE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MALE; MOUTH INFECTION; NONHUMAN; PALATINE TONSIL; PAPILLOMAVIRUS INFECTION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; THROAT CULTURE; TONSIL TUMOR; TONSILLECTOMY; TREATMENT INDICATION; VIRUS DETECTION; ALPHAPAPILLOMAVIRUS; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; SALIVA; VIROLOGY; VIRUS INFECTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PALATINE TONSIL; PAPILLOMAVIRUS INFECTIONS; SALIVA; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 85009754145     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2017.01.001     Document Type: Article

References (32)

1. [1] IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100B: A Review of Human Carcinogens: Biological Agents. Lyon: International Agency for Research on Cancer; 2012.
2. [2] Chaturvedi, A.K., Engels, E.A., Pfeiffer, R.M., Hernandez, B.Y., Xiao, W., Kim, E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29 (2011), 4294–4301.
3. [3] Chaturvedi, A.K., Anderson, W.F., Lortet-Tieulent, J., Curado, M.P., Ferlay, J., Franceschi, S., et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31 (2013), 4550–4559.
4. [4] Giuliano, A.R., Nyitray, A.G., Kreimer, A.R., Pierce Campbell, C.M., Goodman, M.T., Sudenga, S.L., et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer 136 (2015), 2752–2760.
5. [5] Gillison, M.L., Broutian, T., Pickard, R.K., Tong, Z.Y., Xiao, W., Kahle, L., et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307 (2012), 693–703.
6. [6] D'Souza, G., Wentz, A., Kluz, N., Zhang, Y., Sugar, E., Youngfellow, R.M., et al. Sex differences in risk factors and natural history of oral human papillomavirus infection. J Infect Dis 213 (2016), 1893–1896.
7. [7] Castellsague, X., Alemany, L., Quer, M., Halec, G., Quiros, B., Tous, S., et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst, 108, 2016, djv403.
8. [8] Clifford, G.M., Vaccarella, S., Franceschi, S., Tenet, V., Umulisa, M.C., Tshomo, U., et al. Comparison of two widely used human papillomavirus detection and genotyping methods, GP5+/6+-based PCR followed by reverse line blot hybridization and multiplex type-specific E7-based PCR. J Clin Microbiol 54 (2016), 2031–2038.
9. [9] Halec, G., Schmitt, M., Dondog, B., Sharkhuu, E., Wentzensen, N., Gheit, T., et al. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 132 (2013), 63–71.
10. [10] Schmitt, M., Dondog, B., Waterboer, T., Pawlita, M., Tommasino, M., Gheit, T., Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 48 (2010), 143–149.
11. [11] Eklund, C., Zhou, T., Dillner, J., Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 48 (2010), 4147–4155.
12. [12] Haut Conseil de la santé publique, Vaccination contre les infections à papillomavirus humains. 2014, Données actualisées, Paris .
13. [13] Ribeiro, K.M., Alvez, J.M., Pignatari, S.S., Weckx, L.L., Detection of human papilloma virus in the tonsils of children undergoing tonsillectomy. Braz J Infect Dis 10 (2006), 165–168.
14. [14] Ernster, J.A., Sciotto, C.G., O'Brien, M.M., Robinson, L.J., Willson, T., Prevalence of oncogenic human papillomavirus 16 and 18 in the palatine tonsils of the general adult population. Arch Otolaryngol Head Neck Surg 135 (2009), 554–557.
15. [15] Sisk, J., Schweinfurth, J.M., Wang, X.T., Chong, K., Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope 116 (2006), 1372–1374.
16. [16] Cockerill, C.C., Orvidas, L.J., Moore, E.J., Binnicker, M.J., Duresko, B.J., Espy, M.J., et al. Detection of high-risk human papillomavirus infection in tonsillar specimens using 2 commercially available assays. Diagn Microbiol Infect Dis 86 (2016), 365–368.
17. [17] Strome, S.E., Savva, A., Brissett, A.E., Gostout, B.S., Lewis, J., Clayton, A.C., et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8 (2002), 1093–1100.
18. [18] Mammas, I.N., Sourvinos, G., Michael, C., Spandidos, D.A., Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children. Pediatr Infect Dis J 25 (2006), 1158–1162.
19. [19] Syrjanen, S., HPV infections and tonsillar carcinoma. J Clin Pathol 57 (2004), 449–455.
20. [20] Rintala, M.A., Grenman, S.E., Jarvenkyla, M.E., Syrjanen, K.J., Syrjanen, S.M., High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 41 (2005), 1728–1733.
21. [21] Kim, S.H., Koo, B.S., Kang, S., Park, K., Kim, H., Lee, K.R., et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 120 (2007), 1418–1425.
22. [22] Chen, R., Sehr, P., Waterboer, T., Leivo, I., Pawlita, M., Vaheri, A., et al. Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol 43 (2005), 1408–1410.
23. [23] Palmer, E., Newcombe, R.G., Green, A.C., Kelly, C., Noel Gill, O., Hall, G., et al. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions. Int J Cancer 135 (2014), 2437–2443.
24. [24] Fakhry, C., Rosenthal, B.T., Clark, D.P., Gillison, M.L., Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “pap-test equivalent” in high-risk populations. Cancer Prev Res (Phila) 4 (2011), 1378–1384.
25. [25] Franceschi, S., Combes, J.D., Dalstein, V., Caudroy, S., Clifford, G., Gheit, T., et al. Deep brush-based cytology in tonsils resected for benign diseases. Int J Cancer 137 (2015), 2994–2999.
26. [26] Kreimer, A.R., Bhatia, R.K., Messeguer, A.L., Gonzalez, P., Herrero, R., Giuliano, A.R., Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37 (2010), 386–391.
27. [27] Combes, J.D., Chen, A.A., Franceschi, S., Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol Biomarkers Prev 23 (2014), 2954–2958.
28. [28] Kreimer, A.R., Villa, A., Nyitray, A.G., Abrahamsen, M., Papenfuss, M., Smith, D., et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 20 (2011), 172–182.
29. [29] D'Souza, G., Agrawal, Y., Halpern, J., Bodison, S., Gillison, M.L., Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199 (2009), 1263–1269.
30. [30] Cook, R.L., Thompson, E.L., Kelso, N.E., Friary, J., Hosford, J., Barkley, P., et al. Sexual behaviors and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis 41 (2014), 486–492.
31. [31] Kreimer, A.R., Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncol 50 (2014), 555–559.
32. [32] Beachler, D.C., Kreimer, A.R., Schiffman, M., Herrero, R., Wacholder, S., Rodriguez, A.C., et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. J Natl Cancer Inst, 108, 2016.